Dylan Callens

Dylan Callens

Auto-generated profile, based on publicly available information

Dylan Callens

Laboratory of Experimental Radiotherapy, KU Leuven, Leuven, Belgium

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2024 in Radiotherapy and Oncology
Verified
Journal Article
Open access
DCDylan Callens
Dylan Callens
CMCiaran Malone
Ciaran Malone
ACAntony Carver
Antony Carver
CFChristian Fiandra
Christian Fiandra
MGMark J. Gooding
Mark J. Gooding
CCCarlos E. Cardenas
Carlos E. Cardenas
Radiotherapy treatment planning is undergoing a transformation with the increasing integration of automation. This transition draws parallels with the aviation industry, which has a long-standing history of addressing challenges and opportunities introduced by automated systems. Both fields witness a shift from manual operations to systems capable of operating independently, raising questions about the risks and evolving role of humans within automated workflows. In response to this shift, a working group assembled during the ESTRO Physics Workshop 2023, reflected on parallels to draw lessons for radiotherapy. A taxonomy is proposed, leveraging insights from aviation, that outlines the observed levels of automation within the context of radiotherapy and their corresponding implications for human involvement. Among the common identified risks associated with automation integration are complacency, overreliance, attention tunneling, data overload, a lack of transparency and training. These risks require mitigation strategies. Such strategies include ensuring role complementarity, introducing checklists and safety requirements for human-automation interaction and using automation for cognitive unload and workflow management. Focusing on already automated processes, such as dose calculation and auto-contouring as examples, we have translated lessons learned from aviation. It remains crucial to strike a balance between automation and human involvement. While automation offers the potential for increased efficiency and accuracy, it must be complemented by human oversight, expertise, and critical decision-making. The irreplaceable value of human judgment remains, particularly in complex clinical situations. Learning from aviation, we identify a need for human factors engineering research in radiation oncology and a continued requirement for proactive incident learning.

15 March 2024 in Technical Innovations & Patient Support in Radiation Oncology
Verified
Journal Article
Open access
MLMichelle Leech
Michelle Leech
AAAlaa Abdalqader
Alaa Abdalqader
SASophie Alexander
Sophie Alexander
NANigel Anderson
Nigel Anderson
BBBarbara Barbosa
Barbara Barbosa
MBMonica Buijs
Monica Buijs
• This paper describes the future role of the radiation therapist in light of new technological advances, including artificial intelligence. • The paper is co-authored by radiation therapists from all world regions, giving a unique global perspective on the future role of the profession. • Workflows, QA, research, IGRT-ART and clinical decision making are areas of practice that will be influenced by advancing technology.

26 July 2025 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
SPSteven Petit
Steven Petit
Pierfrancesco FrancoPierfrancesco Franco
Pierfrancesco Franco
JHJolien Heukelom
Jolien Heukelom
DCDylan Callens
Dylan Callens

30 December 2024 in Radiography
Verified
Journal Article
Closed access
FSF. Sousa
F. Sousa
JCJ Guilherme Guilherme Couto
J Guilherme Guilherme Couto
DCD. Callens
D. Callens
DGD. Van Gestel
D. Van Gestel

12 January 2024 in Technical Innovations & Patient Support in Radiation Oncology
Verified
Journal Article
Open access
DCDylan Callens
Dylan Callens
KAKarel Aerts
Karel Aerts
PBPatrick Berkovic
Patrick Berkovic
LVLiesbeth Vandewinckele
Liesbeth Vandewinckele
MLMaarten Lambrecht
Maarten Lambrecht
WCWouter Crijns
Wouter Crijns
Decisions for plan-adaptations may be impacted by a transitioning from one dose-calculation algorithm to another. This study examines the impact on dosimetric-triggered offline adaptation in LA-NSCLC in the context of a transition from superposition/convolution dose calculation algorithm (Type-B) to linear Boltzmann equation solver dose calculation algorithms (Type-C). Two dosimetric-triggered offline adaptive treatment workflows are compared in a retrospective planning study on 30 LA-NSCLC patients. One workflow uses a Type-B dose calculation algorithm and the other uses Type-C. Treatment plans were re-calculated on the anatomy of a mid-treatment synthetic-CT utilizing the same algorithm utilized for pre-treatment planning. Assessment for plan-adaptation was evaluated through a decision model based on target coverage and OAR constraint violation. The impact of algorithm during treatment planning was controlled for by recalculating the Type-B plan with Type-C. In the Type-B approach, 13 patients required adaptation due to OAR-constraint violations, while 15 patients required adaptation in the Type-C approach. For 8 out of 30 cases, the decision to adapt was opposite in both approaches. None of the patients in our dataset encountered CTV-target underdosage that necessitated plan-adaptation. Upon recalculating the Type-B approach with the Type-C algorithm, it was shown that 10 of the original Type-B plans revealed clinically relevant dose reductions (≥3%) on the CTV in their original plans. This re-calculation identified 21 plans in total that required ART. In our study, nearly one-third of the cases would have a different decision for plan-adaption when utilizing Type-C instead of Type-B. There was no substantial increase in the total number of plan-adaptations for LA-NSCLC. However, Type-C is more sensitive to altered anatomy during treatment compared to Type-B. Recalculating Type-B plans with the Type-C algorithm revealed an increase from 13 to 21 cases triggering ART.

22 November 2024 in Physics and Imaging in Radiation Oncology
Verified
Journal Article
Open access
LVLiesbeth Vandewinckele
Liesbeth Vandewinckele
CBChahrazad Benazzouz
Chahrazad Benazzouz
LDLaurence Delombaerde
Laurence Delombaerde
LPLaure Pape
Laure Pape
TRTruus Reynders
Truus Reynders
WCWouter Crijns
Wouter Crijns
Background and Purpose: With the increasing amount of in-house created deep learning models in radiotherapy, it is important to know how to minimise the risks associated with the local clinical implementation prior to clinical use. The goal of this study is to give an example of how to identify the risks and find mitigation strategies to reduce these risks in an implemented workflow containing a deep learning based planning tool for breast Volumetric Modulated Arc Therapy. Materials and Methods: The deep learning model ran on a private Google Cloud environment for adequate computational capacity and was integrated into a workflow that could be initiated within the clinical Treatment Planning System (TPS). A proactive Failure Mode and Effect Analysis (FMEA) was conducted by a multidisciplinary team, including physicians, physicists, dosimetrists, technologists, quality managers, and the research and development team. Failure modes categorised as 'Not acceptable' and 'Tolerable' on the risk matrix were further examined to find mitigation strategies. Results: In total, 39 failure modes were defined for the total workflow, divided over four steps. Of these, 33 were deemed 'Acceptable', five 'Tolerable', and one 'Not acceptable'. Mitigation strategies, such as a casespecific Quality Assurance report, additional scripted checks and properties, a pop-up window, and time stamp analysis, reduced the failure modes to two 'Tolerable' and none in the 'Not acceptable' region. Conclusions: The pro-active risk analysis revealed possible risks in the implemented workflow and led to the implementation of mitigation strategies that decreased the risk scores for safer clinical use.